Lemaitre Vascular Stock Net Asset
LMAT Stock | USD 107.97 2.10 1.98% |
LeMaitre Vascular fundamentals help investors to digest information that contributes to LeMaitre Vascular's financial success or failures. It also enables traders to predict the movement of LeMaitre Stock. The fundamental analysis module provides a way to measure LeMaitre Vascular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LeMaitre Vascular stock.
LeMaitre | Net Asset |
LeMaitre Vascular Company Net Asset Analysis
LeMaitre Vascular's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current LeMaitre Vascular Net Asset | 346.78 M |
Most of LeMaitre Vascular's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LeMaitre Vascular is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
LeMaitre Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for LeMaitre Vascular is extremely important. It helps to project a fair market value of LeMaitre Stock properly, considering its historical fundamentals such as Net Asset. Since LeMaitre Vascular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LeMaitre Vascular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LeMaitre Vascular's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
LeMaitre Total Assets
Total Assets |
|
Based on the recorded statements, LeMaitre Vascular has a Net Asset of 346.78 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
LeMaitre Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LeMaitre Vascular's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LeMaitre Vascular could also be used in its relative valuation, which is a method of valuing LeMaitre Vascular by comparing valuation metrics of similar companies.LeMaitre Vascular is currently under evaluation in net asset category among its peers.
LeMaitre Vascular ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LeMaitre Vascular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LeMaitre Vascular's managers, analysts, and investors.Environmental | Governance | Social |
LeMaitre Vascular Institutional Holders
Institutional Holdings refers to the ownership stake in LeMaitre Vascular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of LeMaitre Vascular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LeMaitre Vascular's value.Shares | Northern Trust Corp | 2024-09-30 | 312 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 279.3 K | Acadian Asset Management Llc | 2024-06-30 | 277.5 K | Driehaus Capital Management Llc | 2024-06-30 | 264.2 K | Rice Hall James & Associates, Llc | 2024-09-30 | 261.3 K | Ameriprise Financial Inc | 2024-06-30 | 257.4 K | Envestnet Asset Management Inc | 2024-06-30 | 215.8 K | Bank Of New York Mellon Corp | 2024-06-30 | 210.6 K | Df Dent & Co Inc | 2024-06-30 | 205 K | Blackrock Inc | 2024-06-30 | 3.5 M | Conestoga Capital Advisors, Llc | 2024-09-30 | 2 M |
LeMaitre Fundamentals
Return On Equity | 0.13 | ||||
Return On Asset | 0.0872 | ||||
Profit Margin | 0.19 % | ||||
Operating Margin | 0.24 % | ||||
Current Valuation | 2.22 B | ||||
Shares Outstanding | 22.48 M | ||||
Shares Owned By Insiders | 8.84 % | ||||
Shares Owned By Institutions | 94.21 % | ||||
Number Of Shares Shorted | 784.46 K | ||||
Price To Earning | 38.99 X | ||||
Price To Book | 7.02 X | ||||
Price To Sales | 11.17 X | ||||
Revenue | 193.48 M | ||||
Gross Profit | 104.9 M | ||||
EBITDA | 48.99 M | ||||
Net Income | 30.11 M | ||||
Cash And Equivalents | 75.68 M | ||||
Cash Per Share | 3.45 X | ||||
Total Debt | 19.09 M | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 6.34 X | ||||
Book Value Per Share | 14.72 X | ||||
Cash Flow From Operations | 36.75 M | ||||
Short Ratio | 7.46 X | ||||
Earnings Per Share | 1.82 X | ||||
Price To Earnings To Growth | 2.27 X | ||||
Target Price | 98.78 | ||||
Number Of Employees | 614 | ||||
Beta | 0.89 | ||||
Market Capitalization | 2.38 B | ||||
Total Asset | 346.78 M | ||||
Retained Earnings | 115.43 M | ||||
Working Capital | 164.72 M | ||||
Current Asset | 58.18 M | ||||
Current Liabilities | 10.37 M | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.93 % | ||||
Net Asset | 346.78 M | ||||
Last Dividend Paid | 0.62 |
About LeMaitre Vascular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LeMaitre Vascular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeMaitre Vascular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeMaitre Vascular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.